Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Allergic Contact Dermatitis

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Allergic Contact Dermatitis in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Barbier, O1
Galadari, A1
Milpied, B1
Sanchez, P1
Kassab, S1
Goncalves, R1
Darrigade, AS1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Allergic Contact Dermatitis

ArticleYear
Ecstasy-induced fixed drug eruption.
    Contact dermatitis, 2022, Volume: 87, Issue:3

    Topics: Dermatitis, Allergic Contact; Drug Eruptions; Humans; N-Methyl-3,4-methylenedioxyamphetamine

2022